Enovis Corporation (ENOV) Tops Q4 EPS by 4c; Offers FY23 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. META
5. ISRG
6. TSLA
7. SMCI
8. RTX
9. S
10. COF

Go back to Enovis Corporation (ENOV) Tops Q4 EPS by 4c; Offers FY23 Guidance

Enovis Announces Fourth Quarter and Full Year 2022 Results

February 23, 2023 6:00 AM EST

Wilmington, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Enovis Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced its financial results for the fourth quarter and fiscal year ended December 31, 2022. The Company will host an investor conference call and live webcast to discuss these results today at 8:30 am ET.    Fourth Quarter and Fiscal Year 2022 Financial Results

Enovis fourth quarter net sales of $409 million grew 2% from the prior year, reflecting 5% organic growth offset by a 3% currency headwind. Sales in the Reconstructive segment grew 12%, and 14% on an... More